Search

EHA’s advocacy for hematology continues

The EHA Board has recently approved five position papers which formulate EHA’s key lobbying priorities:

Support for hematology research in Horizon 2020 (and future EU research funding programs)
Access to treatment for patients with blood disorders
EU collaboration to reduce the prices…

Read more

Support opportunities

EHA Ranking for 2024 is now accessible via this link. EHA thrives on the support of the biomedical industry and the medical profession. The variety of opportunities available for industry range from educational activities to the EHA Congress.

Read more

EHA-AHA Hematology Tutorial On Lymphoid Malignancies Attracts International Audience

EHA-AHA Hematology Tutorial on Lymphoid Malignancies

October 18-20, 2019 | Yerevan, Armenia

Meeting chairs:
Prof G Gaidano (European Hematology Association)
Prof Y Hakobyan (Armenian Hematology Association)
Prof S Danielyan (Haematology center after Prof. R. H.

Read more

Membership

Change the world. Make a difference. Improve the lives of many. With more than 6,000 members from 150 countries, EHA is the largest European-based organization that caters to medical professionals, researchers, and scientists with an active interest in hematology.

Read more

Helping steer EHA into the future

In 2020, EHA launched the Taskforce on Diversity, Equity, and Inclusion with an EHA Board mandate.

Read more

Proposal for an EU Regulation on Clinical Trials: A joint statement from non-commercial and commercial organisations

This statement outlines the areas of agreement within the health and research communities on where the Regulation will improve the research environment. Aspects of the Regulation that could be improved to further support clinical research are also highlighted.

Read more